Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decellularized human valve allografts.

R C Elkins1, P E Dawson, S Goldstein

  • 1University of Oklahoma Health Science Center, Oklahoma City, USA.

The Annals of Thoracic Surgery
|June 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preparation of stable maleimide-functionalized au nanoparticles and their use in counting surface ligands.

Small (Weinheim an der Bergstrasse, Germany)·2010
Same author

Manipulation of thrombin exosite I, by ligand-directed covalent modification.

Journal of thrombosis and haemostasis : JTH·2007
Same author

Multicystic, heterogeneously enhancing meningioma in an octogenerian.

British journal of neurosurgery·2005
Same author

Humoral immune response to allograft valve tissue pretreated with an antigen reduction process.

Seminars in thoracic and cardiovascular surgery·2002
Same author

Recellularization of heart valve grafts by a process of adaptive remodeling.

Seminars in thoracic and cardiovascular surgery·2002
Same author

Ross operation in children: late results.

The Journal of heart valve disease·2002
Same journal

Context-Driven Management of Bilateral Diaphragmatic Failure After Phrenic Nerve Sacrifice.

The Annals of thoracic surgery·2026
Same journal

Uncomplicated type B aortic dissection: Are US-based societal guidelines delaying science?

The Annals of thoracic surgery·2026
Same journal

Methodological Paradigms and Clinical Realities in Defining High-Volume Centres for Valve-Sparing Aortic Root Replacement.

The Annals of thoracic surgery·2026
Same journal

Long-Term Outcomes of Concomitant Atrial Fibrillation Management During CABG: Standardization or Compromise?

The Annals of thoracic surgery·2026
Same journal

Ongoing Dialogue and Support for the Future of Congenital Cardiac Surgery.

The Annals of thoracic surgery·2026
Same journal

A Bridge With Gaps.

The Annals of thoracic surgery·2026
See all related articles

SynerGraft decellularization reduces immune response by diminishing antigen content in pulmonary valves. This process preserves valve function and promotes host cell integration for improved long-term durability.

Area of Science:

  • Biomaterials Science
  • Immunology
  • Cardiovascular Surgery

Background:

  • Allograft tissue performance in pediatric and adult patients can be inconsistent due to immune responses.
  • Reducing implant antigenicity is a potential strategy to improve allograft outcomes.

Purpose of the Study:

  • To evaluate the efficacy of SynerGraft decellularization in reducing antigenicity of human and sheep pulmonary valves.
  • To assess the impact of SynerGraft treatment on valve biomechanics, function, and host integration.

Main Methods:

  • Human (CryoValve SG) and sheep pulmonary valves were decellularized using the SynerGraft process.
  • In vitro assessments included histochemical, biomechanical, and hydrodynamic evaluations.
  • In vivo studies involved implantation in sheep and monitoring, alongside implantation in 36 human patients.

Related Experiment Videos

Main Results:

  • SynerGraft treatment significantly reduced tissue antigen expression without compromising human valve biomechanics or strength.
  • Decellularized sheep valves demonstrated functionality and progressive recellularization by host cells post-implantation.
  • Human CryoValve SG pulmonary valves did not elicit a panel reactive antibody response.

Conclusions:

  • SynerGraft decellularization effectively reduces antigen content while preserving the physical properties of pulmonary valves.
  • The reduction in cellularity facilitates host recellularization, potentially enhancing long-term graft durability.